The validity of HIV testing using sputum from suspected tuberculosis patients, Botswana, 2001

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 8, 2003, Pages 710-713

  Talbot, E A ^a   Hone, N M ^b   Moffat, H J ^b   Lee, E J ^a   Moeti, T L ^b   Mokobela, K ^b   Mbulawa, M ^b   Binkin, N J ^a   Wells, Charles D ^a,c   Kenyon, T A ^c  

^a NCHSTP   (United States)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Botswana; Human immunodeficiency virus; Surveillance; Tuberculosis

Indexed keywords

ACCURACY; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPUTUM EXAMINATION; TUBERCULOSIS; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BOTSWANA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUIDELINES; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 0042991281     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Botswana AIDS/STD Unit. Annual Report. Gaborone, Botswana: Ministry of Health, 2000.
2. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with immunodeficiency virus infection. N Engl J Med 1989; 320: 545-550.
3. DeCock K M, Soro B, Coulibaly I-M, Lucas S B. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992; 268: 1581-1587.
4. Selwyn P A, Sckell M B, Alcabes P, et al. High risk of active tuberculosis in HIV infected drug users with cutaneous anergy. JAMA 1992; 268: 504-509.
5. Guelar A, Gatell J M, Verdejo J, et al. A prospective study of the risk of tuberculosis among HIV-infected patients. AIDS 1993; 7: 1345-1349.
6. Allen S, Batungwanayo J, Kerlikowske K, et al. Two year incidence of tuberculosis in cohorts of HIV-infected and uninfected urban Rwandan women. Am Rev Respir Dis 1992; 146: 1439-1444.
7. Botswana National Tuberculosis Program. Annual Report. Gaborone, Botswana: Ministry of Health, 1995.
8. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 1997; 102(3S): 9-14.
9. Emmons W. Accuracy of oral specimen testing for human immunodeficiency virus. Am J Med 1997; 102(3S): 15-20.
10. Tomasi T B. The secretory immune system. In: Stites D P, Stobo J D, Fudenberg H H, Wells J V, eds. Basic and clinical immunology. 5th ed. Los Altos, CA: Lange Medical Publications, 1984: pp 187-196.
11. Gilks C F. Testing sputum samples for HIV antibodies using a rapid, saliva-card test system. Annal Trop Med Parasit 1997; 91: 115-117.